Literature DB >> 1196470

The roles of monoamine neural systems in the anorexia induced by(+)-amphetamine and related compounds.

A S Hollister, G N Ervin, B R Cooper, G R Breese.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1196470     DOI: 10.1016/0028-3908(75)90096-9

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


× No keyword cloud information.
  7 in total

1.  The anorectic action of mazindol.

Authors:  K F Sweeney
Journal:  Ir J Med Sci       Date:  1978-08       Impact factor: 1.568

2.  Diminished amphetamine anorexia and enhanced fenfluramine anorexia after midbrain 6-hydroxydopamine.

Authors:  J E Ahlskog; P K Randall; L Hernandez; B G Hoebel
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

3.  A 5-hydroxytryptamine-like mode of anorectic action for 6-chloro-2-[1-piperazinyl]-pyrazine (MK-212).

Authors:  B V Clineschmidt; J C McGuffin; A B Pflueger; J A Totaro
Journal:  Br J Pharmacol       Date:  1978-04       Impact factor: 8.739

4.  The effect of d-amphetamine and haloperidol alone and in combination on milk drinking in rats.

Authors:  R W Foltin; W L Woolverton; C R Schuster
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

5.  Fenfluramine-induced suppression of food intake and locomotor activity is differentially altered by the selective type A monoamine oxidase inhibitor clorgyline.

Authors:  C S Aulakh; J L Hill; K M Wozniak; D L Murphy
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

6.  Interaction between delta(9)-tetrahydrocannabinol and d-amphetamine.

Authors:  C Hattendorf; M Hattendorf; H Coper; M Fernandes
Journal:  Psychopharmacology (Berl)       Date:  1977-10-20       Impact factor: 4.530

7.  Effects of indorenate on food intake: a comparison with fenfluramine and amphetamine.

Authors:  D N Velázquez Martínez; M Valencia Flores; M López Cabrera; J E Villarreal
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.